{"entity":{"type":"insider","cik":"0001674465","url":"/insider/0001674465","json_url":"/insider/0001674465.json","name":"Levinson Mitchell E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":3,"first":"2017-09-18","last":"2023-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Levinson Mitchell E.","source":"filing","n_filings":3,"first_seen":"2017-09-18","last_seen":"2023-11-17"}],"transactions":[{"id":8006269,"accession":"0001437749-23-032408","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-10","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.9399,"price_display":"5.94","price_state":"stated","total_value":29699.5,"total_display":"29,699.50","shares_owned_after":9135.0,"shares_owned_after_display":"9,135","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006268,"accession":"0001437749-23-032408","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-9","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":5.88,"price_display":"5.88","price_state":"stated","total_value":22344.0,"total_display":"22,344.00","shares_owned_after":73027.0,"shares_owned_after_display":"73,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006267,"accession":"0001437749-23-032408","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-8","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":5.8457,"price_display":"5.85","price_state":"stated","total_value":14029.68,"total_display":"14,029.68","shares_owned_after":3234.0,"shares_owned_after_display":"3,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006266,"accession":"0001437749-23-032408","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-7","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":5.8026,"price_display":"5.80","price_state":"stated","total_value":13926.24,"total_display":"13,926.24","shares_owned_after":3234.0,"shares_owned_after_display":"3,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006265,"accession":"0001437749-23-032408","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-6","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":5.9399,"price_display":"5.94","price_state":"stated","total_value":13661.77,"total_display":"13,661.77","shares_owned_after":3234.0,"shares_owned_after_display":"3,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006264,"accession":"0001437749-23-032408","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-5","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1039.0,"shares_display":"1,039","price_per_share":6.1332,"price_display":"6.13","price_state":"stated","total_value":6372.3948,"total_display":"6,372.39","shares_owned_after":1039.0,"shares_owned_after_display":"1,039","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006263,"accession":"0001437749-23-032408","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":461.0,"shares_display":"461","price_per_share":5.832,"price_display":"5.83","price_state":"stated","total_value":2688.552,"total_display":"2,688.55","shares_owned_after":69227.0,"shares_owned_after_display":"69,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006262,"accession":"0001437749-23-032408","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-3","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":1184.0,"total_display":"1,184.00","shares_owned_after":934.0,"shares_owned_after_display":"934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006261,"accession":"0001437749-23-032408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.94,"price_display":"5.94","price_state":"stated","total_value":594.0,"total_display":"594.00","shares_owned_after":834.0,"shares_owned_after_display":"834","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8006260,"accession":"0001437749-23-032408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-032408","line_url":"/filing/0001437749-23-032408#line-1","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":590.0,"total_display":"590.00","shares_owned_after":834.0,"shares_owned_after_display":"834","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":6527934,"accession":"0001387131-22-010379","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001387131-22-010379","line_url":"/filing/0001387131-22-010379#line-5","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director, Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8810.0,"shares_display":"8,810","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":19998.7,"total_display":"19,998.70","shares_owned_after":12945.0,"shares_owned_after_display":"12,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6527931,"accession":"0001387131-22-010379","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-22-010379","line_url":"/filing/0001387131-22-010379#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director, Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8770.0,"shares_display":"8,770","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":20083.3,"total_display":"20,083.30","shares_owned_after":46274.0,"shares_owned_after_display":"46,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6527929,"accession":"0001387131-22-010379","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-22-010379","line_url":"/filing/0001387131-22-010379#line-3","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director, Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":10035.0,"total_display":"10,035.00","shares_owned_after":5234.0,"shares_owned_after_display":"5,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6527926,"accession":"0001387131-22-010379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-22-010379","line_url":"/filing/0001387131-22-010379#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director, Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4400.0,"shares_display":"4,400","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":9944.0,"total_display":"9,944.00","shares_owned_after":5134.0,"shares_owned_after_display":"5,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6527924,"accession":"0001387131-22-010379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-22-010379","line_url":"/filing/0001387131-22-010379#line-1","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director, Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4300.0,"shares_display":"4,300","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":9847.0,"total_display":"9,847.00","shares_owned_after":5034.0,"shares_owned_after_display":"5,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":4225601,"accession":"0001209191-17-053233","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-053233","line_url":"/filing/0001209191-17-053233#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":12.3575,"price_display":"12.36","price_state":"stated","total_value":30893.75,"total_display":"30,893.75","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider"},{"id":4225595,"accession":"0001209191-17-053233","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-053233","line_url":"/filing/0001209191-17-053233#line-3","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":445.0,"shares_display":"445","price_per_share":12.214,"price_display":"12.21","price_state":"stated","total_value":5435.23,"total_display":"5,435.23","shares_owned_after":445.0,"shares_owned_after_display":"445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider"},{"id":4225586,"accession":"0001209191-17-053233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053233","line_url":"/filing/0001209191-17-053233#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":445.0,"shares_display":"445","price_per_share":12.209,"price_display":"12.21","price_state":"stated","total_value":5433.005,"total_display":"5,433.00","shares_owned_after":445.0,"shares_owned_after_display":"445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider"},{"id":4225578,"accession":"0001209191-17-053233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053233","line_url":"/filing/0001209191-17-053233#line-1","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001674465","owner_name":"Levinson Mitchell E.","owner_url":"/insider/0001674465","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":445.0,"shares_display":"445","price_per_share":12.153,"price_display":"12.15","price_state":"stated","total_value":5408.085,"total_display":"5,408.08","shares_owned_after":445.0,"shares_owned_after_display":"445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001625101","name":"Pulse Biosciences, Inc.","url":"/issuer/0001625101","role":"Director, Officer (Chief Strategy Officer)","n_filings":3,"first_seen":"2017-09-18","last_seen":"2023-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001674465","retrieved_at":"2026-08-21T10:30:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}